NEW YORK CITY — BioLabs, a Boston-based biotechnology incubator and operator of shared lab facilities, has opened a 46,000-square-foot life sciences space in the Long Island City area of Queens. The leased space is located within Innolabs, a 267,000-square-foot facility anchored by NYU Langone Health, and the facility will be known as Biolabs@NYU Langone. A partnership between Boston-based King Street Properties and New York City-based GFP Real Estate owns Innolabs.
PHILADELPHIA — Pharmaceutical giant Eli Lilly (NYSE: LLY) will open a 44,000-square-foot life sciences facility in Philadelphia. The space will span the first and second floors 2300 Market Street, an eight-story, 223,000-square-foot building located roughly midway between the University City and Center City districts. Breakthrough Properties, which is a joint venture between New York City-based Tishman Speyer and biotechnology investment firm Bellco Capital, owns 2300 Market Street, and the facility will be known as Lilly Gateway Labs at Breakthrough. An opening date has not yet been announced.
ST. LOUIS — Tarlton is providing preconstruction and construction management services for “Catalyst: Powered by WashU,” a new startup hub for bioscience companies in the Cortex Innovation District from BOBB LLC, an affiliate of Washington University. The $100 million, 163,000-square-foot redevelopment project is located in the Central West End of St. Louis and includes the renovation of the 120,000-square-foot, seven-story former headquarters of MERS Goodwill Industries at 4140 Forest Park Blvd. Tarlton will restore the building, which was occupied by MERS Goodwill Industries from 1944 to 2019. The building was originally constructed for Standard Sanitary Manufacturing Co. and is listed on the National Register of Historic Places. The project also includes the construction of a new 50,000-square-foot, four-story addition. Three new elevators will access laboratory and office spaces. The ground-floor lobby will feature a coffee bar and common meeting spaces. HOK is the project architect.
WATERTOWN, MASS. — Labshares has signed a 58,000-square-foot life sciences lease in Watertown, a western suburb of Boston. The operator of shared lab facilities will occupy space at 66 Galen St., a newly completed, 225,000-square-foot facility that is part of a larger campus. Bob Richards, Ben Coffin and Sam Crossan of JLL represented the landlord, a partnership between The Davis Cos. and Boston Development Group, in the lease negotiations. Crossan also represented Labshares.
WATERTOWN, MASS. — NanoDx has signed a 20,908-square-foot life sciences lease in Watertown, a western suburb of Boston. The diagnostics company is taking space at 66 Galen St., a newly completed, 225,000-square-foot facility that is part of a larger campus. Stefan Frey of Commonwealth Commercial Advisors represented NanoDx in the lease negotiations. Bob Richards, Ben Coffin and Sam Crossan of JLL represented the landlord, a partnership between The Davis Cos. and Boston Development Group.
HOLLY SPRINGS, N.C. — Ypsomed, a Swiss manufacturer of injection systems for the self-administration of insulin and other liquid medicines, has purchased a life sciences facility in Holly Springs, a suburb of Raleigh. The firm purchased Building H within The Yield Holly Springs from the developer, Charlotte-based Crescent Communities, for $31.5 million. Ypsomed plans to invest $250 million to establish the 110,000-square-foot property as its first manufacturing facility in the United States. Ypsomed plans to customize Building H to be operational in 2027.
CARLSBAD, CALIF. — Cushman & Wakefield has brokered the sale of a single-story life sciences corporate headquarters facility at 2131 Faraday Ave. in Carlsbad. The Wonderful Co. acquired the asset from RPG for $19.3 million. Boston Scientific (NYSE: BSX) fully occupies the 47,075-square-foot property on a triple-net lease basis. The newly renovated, freestanding Class A building features a state-of-the-art central laboratory, high-end corporate offices, onsite amenities, an extensive glass line and robust mechanical systems suited for biotech, medical devices and corporate users. Aric Starck and Drew Dobbs of Cushman & Wakefield represented the seller in the deal.
WOBURN, MASS. — Local developer Cabot, Cabot & Forbes (CC&F) has broken ground on The Bolt, a 180,000-square-foot manufacturing and life sciences facility located north of Boston in Woburn. The Bolt is being developed on a speculative basis and is expected to be responsible for the creation of about 300 new jobs. Jacobs designed the project, and John Moriarty & Associates is serving as the general contractor. Cushman & Wakefield is the leasing agent. Kawa provided $79 million in construction financing for the project, which is expected to be available for occupancy by the second quarter of 2027.
ROCHESTER, MINN. — BioLabs has signed a 16,000-square-foot lease at Two Discovery Square in Rochester. JLL handles leasing for the building in partnership with Mortenson Properties. Slated to open in late 2026, the Rochester site marks the first location in the Midwest for BioLabs. The facility will offer lab and office space for early-stage biotech and HealthTech companies. Discovery Square is an emerging innovation district within walking distance of Mayo Clinic’s flagship campus that offers more than 250,000 square feet of purpose-built space designed for research and technology uses. Jessica Mogilka and William McArdle of JLL led the building leasing efforts.
HOUSTON — General contractor Tellepsen Builders has completed a 10,000-square-foot life sciences facility in northeast Houston. Designed by Pfluger Architects, the facility is known as the San Jacinto College Center for Biotechnology by virtue of its location on that institution’s campus within the Generation Park master-planned development. The center was designed as a laboratory suite with an entry lobby fitted with lockers, a break room and workroom for San Jacinto College students and staff.
Newer Posts